Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth

The naturally occurring oncolytic herpes simplex virus canerpaturev (C-REV), formerly HF10, proved its therapeutic efficacy and safety in multiple clinical trials against melanoma, pancreatic, breast, and head and neck cancers. Meanwhile, patients with colorectal cancer, which has increased in preva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Wu, Zhiwen, Ichinose, Toru, Naoe, Yoshinori, Matsumura, Shigeru, Villalobos, Itzel Bustos, Eissa, Ibrahim Ragab, Yamada, Suguru, Miyajima, Noriyuki, Morimoto, Daishi, Mukoyama, Nobuaki, Nishikawa, Yoko, Koide, Yusuke, Kodera, Yasuhiro, Tanaka, Maki, Kasuya, Hideki
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6539424/
https://ncbi.nlm.nih.gov/pubmed/31193737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.04.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados